Literature DB >> 17382200

Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.

Ivan Spasojević1, Yumin Chen, Teresa J Noel, Yiqun Yu, Marsha P Cole, Lichun Zhang, Yunfeng Zhao, Daret K St Clair, Ines Batinić-Haberle.   

Abstract

The Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnIIITE-2-PyP5+ (AEOL-10113) has proven effective in treating oxidative stress-induced conditions including cancer, radiation damage, diabetes, and central nervous system trauma. The ortho cationic pyridyl nitrogens of MnTE-2-PyP5+ are essential for its high antioxidant potency. The exceptional ability of MnIIITE-2-PyP5+ to dismute O2.- parallels its ability to reduce ONOO- and CO3-. Decreasing levels of these species are considered its predominant mode of action, which may also involve redox regulation of signaling pathways. Recently, Ferrer-Sueta at al. (Free Radic. Biol. Med. 41:503-512; 2006) showed, with submitochondrial particles, that>or=3 microM MnIIITE-2-PyP5+ was able to protect components of the mitochondrial electron transport chain from peroxynitrite-mediated damage. Our study complements their data in showing, for the first time that micromolar mitochondrial concentrations of MnIIITE-2-PyP5+ are obtainable in vivo. For this study we have developed a new and sensitive method for MnIIITE-2-PyP5+ determination in tissues. The method is based on the exchange of porphyrin Mn2+ with Zn2+, followed by the HPLC/fluorescence detection of ZnIITE-2-PyP4+. At 4 and 7 h after a single 10 mg/kg intraperitoneal administration of MnIIITE-2-PyP5+, the mice (8 in total) were anesthetized and perfused with saline. Mitochondria were then isolated by the method of Mela and Seitz (Methods Enzymol.55:39-46; 1979). We found MnIIITE-2-PyP5+ localized in heart mitochondria to 2.95 ng/mg protein. Given the average value of mitochondrial volume of 0.6 microL/mg protein, the calculated MnIIITE-2-PyP5+ concentration is 5.1 microM, which is sufficient to protect mitochondria from oxidative damage. This study establishes, for the first time, that MnIIITE-2-PyP5+, a highly charged metalloporphyrin, is capable of entering mitochondria in vivo at levels sufficient to exert there its antioxidant action; such a result encourages its development as a prospective therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382200      PMCID: PMC1931511          DOI: 10.1016/j.freeradbiomed.2007.01.019

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  48 in total

1.  Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite.

Authors:  Gerardo Ferrer-Sueta; Celia Quijano; Beatriz Alvarez; Rafael Radi
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity.

Authors:  Ayako Okado-Matsumoto; Ines Batinić-Haberle; Irwin Fridovich
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

3.  Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.

Authors:  Ivan Spasojevic; Ines Batinic-Haberle; Julio S Reboucas; Ynara Marina Idemori; Irwin Fridovich
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

4.  Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion.

Authors:  Gerardo Ferrer-Sueta; Dario Vitturi; Ines Batinic-Haberle; Irwin Fridovich; Sara Goldstein; Gidon Czapski; Rafael Radi
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

5.  New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.

Authors:  Ines Batinić-Haberle; Ivan Spasojević; Robert D Stevens; Peter Hambright; Pedatsur Neta; Ayako Okado-Matsumoto; Irwin Fridovich
Journal:  Dalton Trans       Date:  2004-05-05       Impact factor: 4.390

6.  Mouse spinal cord compression injury is ameliorated by intrathecal cationic manganese(III) porphyrin catalytic antioxidant therapy.

Authors:  Huaxin Sheng; Ivan Spasojevic; David S Warner; Ines Batinic-Haberle
Journal:  Neurosci Lett       Date:  2004-08-12       Impact factor: 3.046

7.  Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia.

Authors:  Huaxin Sheng; Jan J Enghild; Russell Bowler; Manisha Patel; Ines Batinić-Haberle; Carla L Calvi; Brian J Day; Robert D Pearlstein; James D Crapo; David S Warner
Journal:  Free Radic Biol Med       Date:  2002-10-01       Impact factor: 7.376

8.  Delivery of bioactive molecules to mitochondria in vivo.

Authors:  Robin A J Smith; Carolyn M Porteous; Alison M Gane; Michael P Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

9.  Tetrahydrobiopterin rapidly reduces the SOD mimic Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl)porphyrin.

Authors:  Ines Batinić-Haberle; Ivan Spasojević; Irwin Fridovich
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

10.  Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity.

Authors:  Hubert M Tse; Martha J Milton; Jon D Piganelli
Journal:  Free Radic Biol Med       Date:  2004-01-15       Impact factor: 7.376

View more
  57 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

2.  Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen.

Authors:  Jade B Aitken; Peter A Lay; T T Hong Duong; Roshanak Aran; Paul K Witting; Hugh H Harris; Barry Lai; Stefan Vogt; Gregory I Giles
Journal:  J Biol Inorg Chem       Date:  2012-02-11       Impact factor: 3.358

3.  Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.

Authors:  Melba C Jaramillo; Margaret M Briehl; Ines Batinic-Haberle; Margaret E Tome
Journal:  Free Radic Biol Med       Date:  2015-02-26       Impact factor: 7.376

Review 4.  Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.

Authors:  Ines Batinic-Haberle; Ivan Spasojevic; Hubert M Tse; Artak Tovmasyan; Zrinka Rajic; Daret K St Clair; Zeljko Vujaskovic; Mark W Dewhirst; Jon D Piganelli
Journal:  Amino Acids       Date:  2010-05-16       Impact factor: 3.520

5.  Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury.

Authors:  Elina Pathak; Lee Ann MacMillan-Crow; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

6.  Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.

Authors:  Tin Weitner; Ivan Kos; Huaxin Sheng; Artak Tovmasyan; Julio S Reboucas; Ping Fan; David S Warner; Zeljko Vujaskovic; Ines Batinic-Haberle; Ivan Spasojevic
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

8.  Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.

Authors:  Leah R Villegas; Dylan Kluck; Carlie Field; Rebecca E Oberley-Deegan; Crystal Woods; Michael E Yeager; Karim C El Kasmi; Rashmin C Savani; Russell P Bowler; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

9.  Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity.

Authors:  Dorothée Lahaye; Kannan Muthukumaran; Chen-Hsiung Hung; Dorota Gryko; Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle; Jonathan S Lindsey
Journal:  Bioorg Med Chem       Date:  2007-08-19       Impact factor: 3.641

10.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.